Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Étienne Brain

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|February 14, 2024
["Vaccinating" against lung cancer?]Étienne Brain
La Revue Du Praticien|February 23, 2026
[Current challenges in geriatric oncology]Camille Chakiba-Brugère, Étienne Brain
La Revue Du Praticien|February 23, 2026
[Breast cancer: an example of changing practices that take age-related factors into account. About the ASTER 70s study]Étienne Brain, Florence Rollot-Trad, Godelieve Rochette de Lempdes, et al.
Bulletin Du Cancer|May 5, 2011
[Brain metastases in breast cancer. Epidemiology and natural history. The Institut Curie experience]Julie Gachet, Julie Giroux, Véronique Girre, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)Pierre Kerbrat, Isabelle Desmoulins, Lise Roca, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|February 14, 2024
["Vaccinating" against lung cancer?]Étienne Brain
La Revue Du Praticien|February 23, 2026
[Current challenges in geriatric oncology]Camille Chakiba-Brugère, Étienne Brain
La Revue Du Praticien|February 23, 2026
[Breast cancer: an example of changing practices that take age-related factors into account. About the ASTER 70s study]Étienne Brain, Florence Rollot-Trad, Godelieve Rochette de Lempdes, et al.
Bulletin Du Cancer|May 5, 2011
[Brain metastases in breast cancer. Epidemiology and natural history. The Institut Curie experience]Julie Gachet, Julie Giroux, Véronique Girre, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)Pierre Kerbrat, Isabelle Desmoulins, Lise Roca, et al.
Pageof 1